IBDEI2GL ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39269,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,39269,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,39269,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,39270,0)
 ;;=E27.3^^152^1993^4
 ;;^UTILITY(U,$J,358.3,39270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39270,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,39270,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,39270,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,39271,0)
 ;;=E29.1^^152^1993^35
 ;;^UTILITY(U,$J,358.3,39271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39271,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,39271,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,39271,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,39272,0)
 ;;=E55.9^^152^1993^42
 ;;^UTILITY(U,$J,358.3,39272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39272,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,39272,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,39272,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,39273,0)
 ;;=E66.01^^152^1993^20
 ;;^UTILITY(U,$J,358.3,39273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39273,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,39273,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,39273,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,39274,0)
 ;;=E66.8^^152^1993^24
 ;;^UTILITY(U,$J,358.3,39274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39274,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,39274,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,39274,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,39275,0)
 ;;=E66.9^^152^1993^25
 ;;^UTILITY(U,$J,358.3,39275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39275,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,39275,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,39275,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,39276,0)
 ;;=E74.39^^152^1993^16
 ;;^UTILITY(U,$J,358.3,39276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39276,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,39276,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,39276,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,39277,0)
 ;;=E83.30^^152^1993^28
 ;;^UTILITY(U,$J,358.3,39277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39277,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,39277,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,39277,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,39278,0)
 ;;=E83.51^^152^1993^9
 ;;^UTILITY(U,$J,358.3,39278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39278,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,39278,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,39278,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,39279,0)
 ;;=E83.52^^152^1993^7
 ;;^UTILITY(U,$J,358.3,39279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39279,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,39279,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,39279,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,39280,0)
 ;;=E87.5^^152^1993^8
 ;;^UTILITY(U,$J,358.3,39280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39280,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,39280,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,39280,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,39281,0)
 ;;=E89.2^^152^1993^30
 ;;^UTILITY(U,$J,358.3,39281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39281,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,39281,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,39281,2)
 ;;=^5003037
